FDA recall D-0386-2024 · initiated Feb 16, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.